469
Participants
Start Date
June 15, 2021
Primary Completion Date
October 2, 2022
Study Completion Date
September 30, 2026
177Lu-PSMA-617
administered intravenously once every 6 weeks (1 cycle) for 6 cycles
68Ga-PSMA-11
single intravenous dose of approximately 150 MBq. Administered dose must not be lower than 111 MBq or higher than 185 MBq (3 - 5 mCi).
ARDT
administered orally on a continuous basis, as per package insert and guidelines
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Vienna
Novartis Investigative Site, Brussels
Novartis Investigative Site, Liège
Novartis Investigative Site, Linz
Novartis Investigative Site, Baden
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Zurich
Novartis Investigative Site, Roeselare
Novartis Investigative Site, Ghent
NYU Laura and Isaac Perlmutter Cancer Center, New York
Memorial Sloan Kettering Cancer Ctr, New York
Mount Sinai Hosp School of Med, New York
Novartis Investigative Site, Santiago Compostela
Novartis Investigative Site, Stockholm
Virginia Oncology Associates, Norfolk
Onco Hemato Asso of SE Virginia, Roanoke
Duke Univ Medical Center, Durham
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Majadahonda
Novartis Investigative Site, Málaga
Novartis Investigative Site, El Palmar
Novartis Investigative Site, Pamplona
University of Florida, Gainesville
Novartis Investigative Site, Bordeaux
Sarah Cannon Research Institute, Nashville
Novartis Investigative Site, Seville
The Ohio State University Comprehensive Cancer Center, Columbus
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Valencia
Novartis Investigative Site, Angers
Medical College Of Wisconsin, Milwaukee
Novartis Investigative Site, Clermont-Ferrand
WA Uni School Of Med, St Louis
Urology Cancer Center PC, Omaha
Nebraska Cancer Specialists, Omaha
Novartis Investigative Site, Lyon
Tulane Uni Health Sciences Center, New Orleans
Novartis Investigative Site, Paris
Uni Of TX MD Anderson Cancer Cntr, Houston
Rocky Mountain Cancer Centers, Denver
Novartis Investigative Site, München
Novartis Investigative Site, Bratislava
Utah Cancer Specialists, Salt Lake City
Novartis Investigative Site, Villejuif
Seattle Cancer Care Alliance, Seattle
Dana Farber Cancer Institute, Boston
Beth Israel Deaconess Med Ctr, Boston
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Maastricht
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Gliwice
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Lund
Novartis Investigative Site, Guildford
Novartis Investigative Site, Sutton
Novartis Investigative Site, Coventry
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Middlesbrough
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY